Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
43 /100
COMPONENT-LIMITED
Score updated Oct 24, 2026

SCTX — Scribe Therapeutics, Inc. Dilution Risk Tracker

Track SCTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SCTX — Get alerts when the score changes →

As of October 24, 2026, Scribe Therapeutics, Inc. (SCTX) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Scribe Therapeutics, Inc. has a market capitalization of $291.64M, 18.93M shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊Float Risk—
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for SCTX.
🔔 Track SCTX — Get forecast alerts →

Market Data

Market Cap$291.64M
Shares Outstanding18.93M
FloatN/A
Cash$43.01M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore43/100DilutionWatch score record
Shares Outstanding18.93MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market Cap$291.64MMarket data cache
Cash Runway20.0 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 5.

Recent SEC source mix: 3 3, 8-K 1, EFFECT 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

SCTX SEC Filing Activity — Last 12 Months

Shares outstanding reported by SCTX on the cover page of its latest 10-K/10-Q: 18.93M as of August 31, 2026.

DilutionWatch recorded no shelf, registration or prospectus documents for SCTX in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
8-Kcurrent report (material event)2Sep 02, 2026
SC 13Gpassive >5% holder filing1Aug 03, 2026
3initial insider ownership15Jul 30, 2026

Institutional Holdings

Institutional data not yet available.

Short Interest

Short Interest2.47M
Days to Cover3.6
% of FloatN/A
FINRA data as of Sep 30, 2026

Recent SEC Activity

8-K 8K EVENT 2026-07-27
3 FORM3 2026-07-23
3 FORM3 2026-07-23
EFFECT EFFECT 2026-07-23
3 FORM3 2026-07-23
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual SCTX Dilution Snapshot

Scribe Therapeutics, Inc. (SCTX) has a DilutionScore of 43/100, rated Medium dilution risk. Score date: October 24, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

SCTX's DilutionScore is currently 43/100 (Medium risk), with 2 score changes tracked over 89 days. The score deteriorated from 48/100 (Medium risk).

Period Score Risk Level Duration
Oct 05 – Oct 24, 202643/100MEDIUM20 days
Sep 08 – Oct 04, 202648/100MEDIUM27 days
Jul 27 – Sep 07, 202640/100MEDIUM42 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track SCTX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment SCTX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking SCTX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,550+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note